CALCR and metastatic malignant neoplasm: Recently calcitonin and calcitonin receptor (CTR) have been demonstrated to be highly expressed in advanced grades of prostate carcinoma; calcitonin and CTR are supposed to be involved in a favourable paracrine axis able to induce the progression from a localized to a metastatic cancer [22].